ACSL4 and breast cancer: In breast cancer, STAT3 promotes ferroptosis by increasing ACSL4 expression, while in ulcerative colitis (UC) cell models, STAT3 phosphorylation is downregulated, and the ferroptosis inhibitor Fer-1 can restore its phosphorylation [39].